Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Colorado State University
AIDS Malignancy Consortium
Taiho Oncology, Inc.
Essen Biotech
Institut Bergonié
Adela, Inc
OncoNano Medicine, Inc.
University Health Network, Toronto
Incyte Corporation
Washington University School of Medicine
Incyte Corporation
Institut Bergonié
Novartis
Tempus AI
Region Skane
University Health Network, Toronto
RAPT Therapeutics, Inc.
VitaMed Research LLC
ModernaTX, Inc.
Cedars-Sinai Medical Center
Sanguine Biosciences
Stingthera, Inc.
Fate Therapeutics
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Fate Therapeutics
Blue Note Therapeutics
Incyte Corporation
Institut Bergonié
AstraZeneca
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
AIDS Malignancy Consortium
Jonsson Comprehensive Cancer Center
MultiVir, Inc.
Celgene
Tocagen Inc.
Shenzhen BinDeBio Ltd.
Vanderbilt-Ingram Cancer Center
Tel-Aviv Sourasky Medical Center
Novartis
Masonic Cancer Center, University of Minnesota
GlaxoSmithKline
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Amgen
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center